Purchase Order 75N94020P00677

The Department of Health and Human Services National Institutes of Health National Institute on Alcohol Abuse and Alcoholism awarded a $13,578 purchase order to Molecular Devices LLC for a SPECTRAMAX ABS SINGLEMODE MICROPLATE READER SYSTEM. As part of NIH's ongoing research efforts, this fixed price contract will provide Molecular Devices' single-mode microplate reader to support analysis capabilities through October 9, 2023. Molecular Devices, located in San Jose, California, will deliver the...

<p>The National Institute on Alcohol Abuse and Alcoholism awarded a purchase order to Life Technologies Corporation on December 30, 2018, with a ceiling value of $40,905.00 for firm fixed price delivery of laboratory instrumentation, reagents, or consumables. Place of performance is Carlsbad, California. The order completed on February 26, 2020. The originating pre-solicitation opportunity posted on December 12, 2018, with a due date of December 21, 2018.</p>

<p>The National Institute on Alcohol Abuse and Alcoholism awarded a purchase order to Life Technologies Corporation for $109,676.46 on August 7, 2026, for whole-exome sequencing enrichment and regents to identify rare sequence variants across protein-coding sequences in newly recruited patients with alcohol-related phenotypes. Work is performed in Carlsbad, California. The order is firm fixed price with an ultimate completion date of August 6, 2027.</p>

<p>The National Institute on Alcohol Abuse and Alcoholism awarded a purchase order to Horiba Instruments Incorporated for $11,399.00 on August 21, 2020. Place of performance is Piscataway, New Jersey. The order is firm fixed price with no small business set-aside. Ultimate completion date is September 12, 2020.</p>

<p>The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a purchase order to Inscopix, Inc. on July 23, 2020, for $116,500 to supply an nVoke 2.0 integrated imaging and optogenetics system. Performance takes place in Palo Alto, California. The order carries fixed-price, award-fee pricing and is not set-aside. The originating solicitation was posted July 2, 2020, with a due date of July 16, 2020. Ultimate completion is scheduled for September 21, 2020.</p>

<p>The National Institute on Alcohol Abuse and Alcoholism awarded a purchase order to Inscopix, Inc. for $119,000.00 on September 3, 2019, for the nVoke 2.0 integrated imaging and optogenetics system. Place of performance is Bethesda, Maryland. The order is firm fixed-price with no set-aside designation and an ultimate completion date of October 31, 2019. The underlying solicitation was posted on July 26, 2019, with a due date of August 9, 2019.</p>

<p>The National Institute on Alcohol Abuse and Alcoholism issued a $10,129 delivery order to Beckman Coulter, Inc. on January 15, 2020, for biomedical laboratory equipment and related services. Place of performance is North Bethesda, MD. The order carries a firm fixed price and ultimate completion date of January 14, 2021.</p>

The National Institute on Alcohol Abuse and Alcoholism awarded a purchase order to Human Metabolome Technologies America, Inc. for $17,000.00 on June 18, 2026, with final completion by June 17, 2027. The order is firm fixed price with no set-aside category. Performance occurs in Boston, Massachusetts. The National Institute on Alcohol Abuse and Alcoholism conducts studies to determine the contribution of genetics and metabolomics in the etiology of substance abuse disorders through the...

<p>The National Institute on Alcohol Abuse and Alcoholism issued a delivery order to Thermo Electron North America LLC on June 19, 2019, with a ceiling value of $35,480.35 under the GSA Multiple Award Schedule (Scientific Equipment and Services, FSS-66). Ultimate completion date is June 18, 2020. Place of performance is North Bethesda, MD. The order is priced on a firm fixed-price basis with no set-aside applied.</p>

The National Institute on Alcohol Abuse and Alcoholism awarded a purchase order to Bio-Rad Laboratories, Inc. for $14,999.00 on September 15, 2026, for operation and calibration services on a digital PCR system with automated droplet generation. This is a firm fixed-price purchase order with no set-aside. Performance occurs in Rodeo, California, with an ultimate completion date of September 14, 2027. The instrument supports gene expression analysis across multiple mission-critical research...